From August 30, 2023 to September 30, 2023, the company has repurchased 173,000 shares, representing 0.09% for CNY 3.32 million. With this, the company has completed the repurchase of 173,000 shares, representing 0.09% for CNY 3.32 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.98 CNY | -0.88% | -5.09% | -21.79% |
1st Jan change | Capi. | |
---|---|---|
-21.79% | 463M | |
+31.06% | 688B | |
+30.35% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.53% | 239B | |
+10.16% | 210B | |
-8.14% | 200B | |
+8.12% | 167B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.